The Experts below are selected from a list of 72 Experts worldwide ranked by ideXlab platform
Dan Engelhard - One of the best experts on this subject based on the ideXlab platform.
-
nosocomial colonization septicemia and hickman Broviac Catheter related infections in bone marrow transplant recipients a 5 year prospective study
Medicine, 1998Co-Authors: Hanita Elishoov, Nurith Strauss, Dan EngelhardAbstract:In this 5-year prospective study of 242 bone marrow transplantation (BMT) recipients from whom daily blood cultures via the indwelling Broviac/Hickman Catheter were obtained, there was a median of 35 Catheter-days during hospitalization, mean of 40 days, and total of 9,667 Catheter-days which were divided almost equally between neutropenic (4,771) and non-neutropenic (4,896) days. One hundred twenty (50%) patients had a total of 161 episodes of nosocomial bacterial or candidal infections. Overall, 81 (33%) patients experienced 100 episodes of Catheter-related infections and 90 (37%) patients experienced 112 episodes of septicemia, including 51 episodes of Catheter-related septicemia. There was an incidence of 11.59 septicemia episodes, including 5.28 Catheter-related septicemia episodes, 2.48 colonization only (without subsequent septicemia), and 2.59 exit site infections only, per 1,000 Catheter-days. Over a period of a total of 6,593 afebrile days, 34 (14%) patients developed 40 episodes of colonization, a rate of 6.07 per 1,000 afebrile days, of which 16 developed into septicemia. Twenty-five patients had 1 episode each of exit site infection without bacteremia. There were 10 (4%) septicemia-related deaths, 4 of which were Catheter-related; 50% of all deaths involved Pseudomonas aeruginosa. The mortality due to Catheter-related septicemic episodes was not greater than that of the non-Catheter-related episodes. Neutropenia was found to be a significant risk factor in our study: 76% of the septicemia episodes (85/112) and 65% of the Catheter-related infectious episodes (65/100) occurred during neutropenia. There was a higher incidence of septicemic episodes during neutropenia than during non-neutropenic periods, 17.82 versus 5.51 per 1,000 days (p < 0.0001), and a higher rate of Catheter-related infections during the neutropenic period, 13.62 versus 7.15 during non-neutropenic days per 1,000 days (0.001). Fourteen of 16 colonization episodes developed into septicemia during neutropenia versus 2/24 during non-neutropenic periods, a rate of 5.47 versus 0.47 per 1,000 afebrile days, respectively (p < 0.0001), and 9/10 deaths occurred during neutropenia.
Hanita Elishoov - One of the best experts on this subject based on the ideXlab platform.
-
nosocomial colonization septicemia and hickman Broviac Catheter related infections in bone marrow transplant recipients a 5 year prospective study
Medicine, 1998Co-Authors: Hanita Elishoov, Nurith Strauss, Dan EngelhardAbstract:In this 5-year prospective study of 242 bone marrow transplantation (BMT) recipients from whom daily blood cultures via the indwelling Broviac/Hickman Catheter were obtained, there was a median of 35 Catheter-days during hospitalization, mean of 40 days, and total of 9,667 Catheter-days which were divided almost equally between neutropenic (4,771) and non-neutropenic (4,896) days. One hundred twenty (50%) patients had a total of 161 episodes of nosocomial bacterial or candidal infections. Overall, 81 (33%) patients experienced 100 episodes of Catheter-related infections and 90 (37%) patients experienced 112 episodes of septicemia, including 51 episodes of Catheter-related septicemia. There was an incidence of 11.59 septicemia episodes, including 5.28 Catheter-related septicemia episodes, 2.48 colonization only (without subsequent septicemia), and 2.59 exit site infections only, per 1,000 Catheter-days. Over a period of a total of 6,593 afebrile days, 34 (14%) patients developed 40 episodes of colonization, a rate of 6.07 per 1,000 afebrile days, of which 16 developed into septicemia. Twenty-five patients had 1 episode each of exit site infection without bacteremia. There were 10 (4%) septicemia-related deaths, 4 of which were Catheter-related; 50% of all deaths involved Pseudomonas aeruginosa. The mortality due to Catheter-related septicemic episodes was not greater than that of the non-Catheter-related episodes. Neutropenia was found to be a significant risk factor in our study: 76% of the septicemia episodes (85/112) and 65% of the Catheter-related infectious episodes (65/100) occurred during neutropenia. There was a higher incidence of septicemic episodes during neutropenia than during non-neutropenic periods, 17.82 versus 5.51 per 1,000 days (p < 0.0001), and a higher rate of Catheter-related infections during the neutropenic period, 13.62 versus 7.15 during non-neutropenic days per 1,000 days (0.001). Fourteen of 16 colonization episodes developed into septicemia during neutropenia versus 2/24 during non-neutropenic periods, a rate of 5.47 versus 0.47 per 1,000 afebrile days, respectively (p < 0.0001), and 9/10 deaths occurred during neutropenia.
Cecile Chambrier - One of the best experts on this subject based on the ideXlab platform.
-
a comparative study of peripherally inserted and Broviac Catheter complications in home parenteral nutrition patients
Clinical Nutrition, 2015Co-Authors: A Toure, A Duchamp, C Peraldi, D Barnoud, M Lauverjat, P Gelas, Cecile ChambrierAbstract:Summary Background & aims Peripherally inserted central venous Catheters (PICC) have become increasingly popular for medium to long-term parenteral nutrition (PN) but there is limited data on the complication rates in this sub-group. We aimed to compare the rates of complications associated with tunneled Catheters (Broviac) and PICC in home PN (HPN) patients. Methods All adult patients in an HPN program with a new Broviac or new PICC between 2009 and 2011 were included in this prospective observational study. Complication rates were compared by using Poisson regression and Kaplan Meier survival curves were used to compare the first complications that occurred. Results 204 Catheters (133 Broviac and 71 PICC) were inserted in 196 adult patients. Mean follow-up from Catheter insertions to their removal was 276 ± 219 days for Broviac ( n = 86) vs. 74 ± 140.70 days for PICC ( n = 56); p p = 0.01). Catheter obstruction rates were similar for both Catheters. Only PICC experienced venous thrombosis (0.4/1000). The proportion of Catheters removed was lower in the Broviac group than in the PICC group (62.4% vs. 78.8%; p = 0.01) but those removed for complications were not different (28.6.7%vs. 25.3%; p = 0.64). Conclusions In HPN patients, overall complications were similar in both the PICC and the Broviac groups. However, the Broviac Catheter could be associated with an increase in Catheter infection.
Alessandra Rocha Lima - One of the best experts on this subject based on the ideXlab platform.
-
Cuidados com o paciente que utiliza o cateter de Hickman-Broviac: um estudo de caso Caring the patient wicth Hickman-Broviac Catheter: a case study
Universidade de São Paulo, 1998Co-Authors: Luciana Monteiro Mendes Martins, Alessandra Rocha LimaAbstract:As autoras fazem uma breve revisão de literatura sobre o cateter de Hickman-Broviac e posteriormente, analisam os conhecimentos da equipe de enfermagem em relação a este cateter e as orientações fornecidas para um paciente que vai para casa utilizando o cateter de Hickman-Broviac, assim como as orientações assimiladas pelo mesmo.Caring the patient with Hickman-Broviac Catheter: a case study. The authors make a shori literature review about the Hickman-Broviac Catheter and after they analyse and coment about the nursing staff's knowledge and patient's self care related to this Catheter
Nurith Strauss - One of the best experts on this subject based on the ideXlab platform.
-
nosocomial colonization septicemia and hickman Broviac Catheter related infections in bone marrow transplant recipients a 5 year prospective study
Medicine, 1998Co-Authors: Hanita Elishoov, Nurith Strauss, Dan EngelhardAbstract:In this 5-year prospective study of 242 bone marrow transplantation (BMT) recipients from whom daily blood cultures via the indwelling Broviac/Hickman Catheter were obtained, there was a median of 35 Catheter-days during hospitalization, mean of 40 days, and total of 9,667 Catheter-days which were divided almost equally between neutropenic (4,771) and non-neutropenic (4,896) days. One hundred twenty (50%) patients had a total of 161 episodes of nosocomial bacterial or candidal infections. Overall, 81 (33%) patients experienced 100 episodes of Catheter-related infections and 90 (37%) patients experienced 112 episodes of septicemia, including 51 episodes of Catheter-related septicemia. There was an incidence of 11.59 septicemia episodes, including 5.28 Catheter-related septicemia episodes, 2.48 colonization only (without subsequent septicemia), and 2.59 exit site infections only, per 1,000 Catheter-days. Over a period of a total of 6,593 afebrile days, 34 (14%) patients developed 40 episodes of colonization, a rate of 6.07 per 1,000 afebrile days, of which 16 developed into septicemia. Twenty-five patients had 1 episode each of exit site infection without bacteremia. There were 10 (4%) septicemia-related deaths, 4 of which were Catheter-related; 50% of all deaths involved Pseudomonas aeruginosa. The mortality due to Catheter-related septicemic episodes was not greater than that of the non-Catheter-related episodes. Neutropenia was found to be a significant risk factor in our study: 76% of the septicemia episodes (85/112) and 65% of the Catheter-related infectious episodes (65/100) occurred during neutropenia. There was a higher incidence of septicemic episodes during neutropenia than during non-neutropenic periods, 17.82 versus 5.51 per 1,000 days (p < 0.0001), and a higher rate of Catheter-related infections during the neutropenic period, 13.62 versus 7.15 during non-neutropenic days per 1,000 days (0.001). Fourteen of 16 colonization episodes developed into septicemia during neutropenia versus 2/24 during non-neutropenic periods, a rate of 5.47 versus 0.47 per 1,000 afebrile days, respectively (p < 0.0001), and 9/10 deaths occurred during neutropenia.
